Company news
Stoke Therapeutics, Inc. news in 2019
Stoke Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Stoke Therapeutics Added to NASDAQ Biotechnology Index
December 22, 2019
Stoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet Syndrome
December 7, 2019
Stoke Therapeutics Presents Preclinical Data From Studies of STK-001 That Showed Improvements in Survival and Reductions in Seizure Frequency in a Mouse Model of Dravet Syndrome
December 6, 2019
Stoke Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
Stoke Therapeutics to Present New Preclinical Data on STK-001 at the American Epilepsy Society Annual Meeting
November 24, 2019
Stoke Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
November 11, 2019
Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human Resources
October 15, 2019
Stoke Therapeutics to Present at 2019 Cantor Global Healthcare Conference
September 29, 2019
Stoke Therapeutics Added to Russell 2000 and 3000 Indexes
September 10, 2019